デフォルト表紙
市場調査レポート
商品コード
1529604

スマート吸入器の市場規模、シェア、動向分析:タイプ別、適応症別、流通チャネル別、最終用途別、地域別、セグメント別予測、2024年~2030年

Smart Inhalers Market Size, Share & Trends Analysis Report By Type, By Indication, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 125 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.74円
スマート吸入器の市場規模、シェア、動向分析:タイプ別、適応症別、流通チャネル別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年07月26日
発行: Grand View Research
ページ情報: 英文 125 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

スマート吸入器市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のスマート吸入器の市場規模は2030年までに533億米ドルに達し、2024年から2030年までのCAGRは19.4%で成長すると予測されています。

スマート吸入器市場の成長は、呼吸器疾患の有病率の上昇、意識向上イニシアチブの増加、医療機器へのデジタル技術の統合、市場プレイヤーによる先進製品の開拓など、いくつかの主要な要因によって牽引されています。公害や免疫力低下によって悪化した慢性呼吸器疾患、特に喘息やCOPDの世界の増加は、吸入器の需要を煽っています。米国肺協会によると、米国では2022年に成人の4.6%にあたる約1,170万人がCOPDと診断され、技術的に進歩した吸入器の需要を押し上げると予想されています。

スマート吸入器は、投与量リマインダー、健康状態の追跡、アドヒアランスサポート、データに基づくインサイトなど、従来の吸入器にはない利点を提供します。市場のプレーヤーは、進化する需要を満たすために革新的なソリューションに積極的に投資しています。例えば、Aptar Pharmaは2022年4月にHeroTracker Senseを発表し、従来の吸入器をスマートデバイスに変え、2020年1月にはLupin Limitedと提携し、「MyAdhero」アプリケーションを介して薬の使用状況を追跡するADHEROデバイスを発売しました。これらの進歩は、スマート吸入器の世界需要を促進すると予想されます。

さらに、政府や民間セクターの取り組みにより、呼吸器疾患に対する意識が高まっています。2022年11月に開始された米国肺協会の「COPDへの取り組み」プロジェクトは、米国内の1,250万人のCOPD患者のケアを改善することを目的としています。このような取り組みは、高度なデバイスの利用可能性の高まりと相まって、スマート吸入器市場の成長に大きく寄与しています。

スマート吸入器市場レポートハイライト

  • タイプ別に、市場は乾燥粉末吸入器(DPI)と定量吸入器(MDI)に区分されます。MDIセグメントは2023年に64.0%の最大収益シェアを占め、2024年から2030年にかけて最も速い成長が予測されます。これは、MDIが短時間に噴霧する定量噴霧器として使いやすく、人気が高まっているためです。
  • 適応症に基づき、市場は喘息、慢性閉塞性肺疾患(COPD)、その他に区分されます。COPDセグメントは、世界的にCOPDの有病率が高く、この疾患に対する認識が高まっていることから、2023年の売上高シェアは50.7%で市場を独占しています。さらに、その他のセグメントは予測期間中にCAGR 21.8%と最速の成長を示すと予測されています。
  • 市場は流通チャネル別に病院、小売、オンライン薬局に区分されます。病院薬局セグメントは2023年に44.3%の最大の収益シェアを占めました。病院薬局は、入院患者のためのスマート吸入器の購入に、より優れた柔軟性、快適性、利便性を提供します。また、オンライン薬局セグメントは予測期間中22.1%のCAGRで最速の成長が見込まれています。
  • 最終用途に基づき、市場は病院、在宅医療、その他に区分されます。病院セグメントは2023年の市場シェア51.3%で市場を独占しています。成長の背景には、医療インフラの急速な進歩と官民連携の拡大があります。在宅医療セグメントは、2024年から2030年にかけてCAGR 20.3%で急成長すると予測されています。
  • 2023年には、北米が45.1%と最大の収益シェアを占めましたが、これは医療インフラの発達と先進医療機器の採用によるものです。しかし、アジア太平洋地域は、デジタル医療機器の採用が増加し、スマート吸入器の利点に対する認識が高まっていることから、CAGR 21.2%で最速の成長を遂げると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 スマート吸入器市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場見通し
  • 業界分析
    • ユーザーの視点分析
    • 主なエンドユーザー
  • テクノロジー展望
  • 規制の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の課題と機会の分析
  • スマート吸入器市場分析ツール
    • ポーターの分析
    • PESTEL分析
  • スマート吸入器業界における主要取引と戦略的提携の分析
  • COVID-19の影響

第4章 スマート吸入器市場:タイプの推定・動向分析

  • 定義と範囲
  • タイプの市場シェア分析、2023年・2030年
  • セグメントダッシュボード
  • スマート吸入器市場:タイプ別、2018~2030年

第5章 スマート吸入器市場:適応症の推定・動向分析

  • 定義と範囲
  • 適応症の市場シェア分析、2023年・2030年
  • セグメントダッシュボード
  • スマート吸入器市場:適応症別、2018~2030年

第6章 スマート吸入器市場:流通チャネルの推定・動向分析

  • 定義と範囲
  • 流通チャネルの市場シェア分析、2023年・2030年
  • セグメントダッシュボード
  • スマート吸入器市場:流通チャネル別、2018~2030年

第7章 スマート吸入器市場:最終用途の推定・動向分析

  • 定義と範囲
  • 最終用途の市場シェア分析、2023年・2030年
  • セグメントダッシュボード
  • スマート吸入器市場:最終用途別、2018~2030年

第8章 スマート吸入器市場:地域の推定・動向分析、国別、タイプ別、適応症別、流通チャネル別、最終用途別

  • 定義と範囲
  • 地域の市場シェア分析、2023年・2030年
  • 地域市場ダッシュボード
  • 地域市場スナップショット
  • SWOT分析
  • スマート吸入器市場シェア、地域別、2023年・2030年、10億米ドル
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業の市場シェア分析
  • 企業ヒートマップ分析
  • 戦略マッピング
    • 拡大
    • 合併と買収
    • パートナーシップとコラボレーション
    • 新製品の発売
    • 研究開発
  • 企業プロファイル
    • Presspart Verwaltungs GmbH.
    • Personal Air Quality Systems Pvt Ltd
    • COHERO Health Inc.(AptarGroup, Inc.)
    • Cognita Labs
    • adherium
    • Amiko Digital Health Limited.
    • Teva Pharmaceuticals Industries Ltd.
    • Propeller Health(ResMed)
    • Novartis AG
    • Pneuma Respiratory Inc.
    • 3M
    • AireHealth, Inc.
    • FindAir Sp. z oo
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 4 North America smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 5 North America smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 9 U.S. smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 13 Canada smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 Canada smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 17 Europe smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 Europe smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 19 UK smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 20 UK smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 21 UK smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 UK smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 25 Germany smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Germany smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 27 France smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 28 France smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 29 France smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 France smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 31 Italy smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 32 Italy smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 33 Italy smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Italy smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 37 Spain smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38 Spain smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 39 Russia smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 40 Russia smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 41 Russia smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Russia smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 49 Japan smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 Japan smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 51 China smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 52 China smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 53 China smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 China smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 55 India smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 56 India smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 57 India smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 India smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 60 Australia smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 61 Australia smart inhalers market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 Australia smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 64 South Korea smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 65 South Korea smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 66 Singapore smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 67 Singapore smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 68 Singapore smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 69 Singapore smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 72 Latin America smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 73 Latin America smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 75 Brazil smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 76 Brazil smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 77 Brazil smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 78 Mexico smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 79 Mexico smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 80 Mexico smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 Mexico smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 82 Argentina smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 83 Argentina smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 84 Argentina smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 85 Argentina smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 86 MEA smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 87 MEA smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 88 MEA smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 89 MEA smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 90 South Africa smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 91 South Africa smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 92 South Africa smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 93 South Africa smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 97 Saudi Arabia smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 98 UAE smart inhalers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
  • Table 99 UAE smart inhalers market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 100 UAE smart inhalers market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
  • Table 101 UAE smart inhalers market estimates and forecasts by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Smart Inhalers Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Smart Inhalers - Market Size and Growth Prospects (USD Million)
  • Fig. 12 Smart Inhalers Market : Industry Value Chain Analysis
  • Fig. 13 Smart Inhalers Market : Market Dynamics
  • Fig. 14 Smart Inhalers Market : PORTER's Analysis
  • Fig. 15 Smart Inhalers Market : PESTEL Analysis
  • Fig. 16 Smart Inhalers Market Share by type 2023 & 2030 (USD Million)
  • Fig. 17 Smart Inhalers Market ,by type: Market Share, 2023 & 2030
  • Fig. 18 Dry Powedered Inhalers (DPIs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Metered Dose Ihalers (MDIs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Smart Inhalers Market , by Indication: Key Takeaways
  • Fig. 21 Smart Inhalers Market , by Indication: Market Share, 2023 & 2030
  • Fig. 22 Asthma Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 23 COPD Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 25 Smart Inhalers Market , by Distribution Channel: Key Takeaways
  • Fig. 26 Smart Inhalers Market , by Distribution Channel: Market Share, 2023 & 2030
  • Fig. 27 Hospital Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 28 Retail Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 29 Online Pharmacies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 Smart Inhalers Market , by End Use: Key Takeaways
  • Fig. 31 Smart Inhalers Market , by End Use: Market Share, 2023 & 2030
  • Fig. 32 Hospitals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 33 Homecare Settings Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 34 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 35 Smart Inhalers Market Revenue, by Region, 2023 & 2030 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 Regional Marketplace: Key Takeaways
  • Fig. 38 North America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK Smart Inhalers Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
  • Fig. 43 Germany Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 44 France Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 45 Italy Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 46 Spain Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 47 Russia Smart Inhalers Market Estimates and Forecasts (2018 - 2030,) (USD Million)
  • Fig. 48 Asia Pacific Smart Inhalers Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 China Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 India Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Singapore Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 MEA Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key Company Categorization
  • Fig. 63 Company Market Positioning
  • Fig. 64 Key Company Market Share Analysis, 2023
  • Fig. 65 Strategic Framework
目次
Product Code: GVR-4-68039-993-1

Smart Inhalers Market Growth & Trends:

The global smart inhalers market size is expected to reach USD 53.3 billion by 2030 and is projected to grow at a CAGR of 19.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the smart inhaler market is driven by several key factors, including the rising prevalence of respiratory diseases, increased awareness initiatives, the integration of digital technologies in medical devices, and the development of advanced products by market players. The global rise in chronic respiratory diseases, exacerbated by pollution and low immunity, particularly asthma and COPD, fuels demand for inhalers. According to the American Lung Association, approximately 11.7 million people in the U.S., or 4.6% of adults, were diagnosed with COPD in 2022, which is expected to boost demand for technologically advanced inhalers.

Smart inhalers offer benefits over traditional ones, such as dosage reminders, health tracking, adherence support, and data-driven insights. Market players are actively investing in innovative solutions to meet evolving demands. For example, Aptar Pharma introduced HeroTracker Sense in April 2022, transforming conventional inhalers into smart devices, and partnered with Lupin Limited in January 2020 to launch the ADHERO device, which tracks medication usage via the "MyAdhero" application. These advancements are anticipated to drive global demand for smart inhalers.

In addition, government and private sector initiatives are enhancing awareness about respiratory diseases. The American Lung Association's "Addressing COPD" project, launched in November 2022, aims to improve the care of 12.5 million COPD patients in the U.S. Such efforts, combined with the growing availability of advanced devices, significantly contribute to the smart inhaler market's growth.

Smart Inhalers Market Report Highlights:

  • Based on type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). The MDI segment held the largest revenue share of 64.0% in 2023 and is anticipated to witness fastest growth from 2024 to 2030. This is attributable to their increasing popularity as they are easy to use in fixed-dose short bursts sprays
  • Based on indication, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and others. The COPD segment dominated the market with a revenue share of 50.7% in 2023, owing to the high prevalence of COPD globally and increasing awareness about this disease. Moreover, the other segment is anticipated to showcase the fastest growth of CAGR 21.8% over the forecast period
  • Based on distribution channel, the market is segmented into hospital, retail, and online pharmacies. The hospital pharmacies segment held the largest revenue share of 44.3% in 2023. Hospital pharmacies offer better flexibility, comfort, and convenience for purchasing smart inhalers for hospitalized patients. In addition, the online pharmacies segment is expected to grow at the fastest CAGR of 22.1% over the forecast period
  • Based on end use, the market is segmented into hospitals, home care settings, and others. The hospitals segment dominated the market with a market share of 51.3% in 2023. The growth is attributed to the rapid advancements in healthcare infrastructure and expanding public-private partnerships. The home care settings segment is anticipated to showcase fastest growth at a CAGR 20.3% from 2024 to 2030
  • In 2023, North America held the largest revenue share of 45.1%, due to its developed healthcare infrastructure and adoption of advanced medical devices. However, Asia Pacific is projected to experience the fastest growth at a CAGR of 21.2%, driven by increasing adoption of digital medical devices and rising awareness of smart inhaler benefits in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Indication Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Smart Inhalers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising prevalence of respiratory diseases
      • 3.5.1.2. Development of technologically advanced solutions
      • 3.5.1.3. Growing adoption of digital health technologies
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. Higher cost than traditional inhalers
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Smart Inhalers Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal landscape
  • 3.7. Major Deals & Strategic Alliances Analysis in the Smart Inhalers Industry
  • 3.8. Impact of COVID-19

Chapter 4. Smart Inhalers Market: Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Smart Inhalers Market: By Type, 2018 to 2030
    • 4.4.1. Dry Powdered Inhalers (DPIs)
      • 4.4.1.1. Dry Powdered Inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. Metered Dose Inhalers (MDIs)
      • 4.4.2.1. Metered Dose Inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Smart Inhalers Market: Indication Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Indication Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Smart Inhalers Market: By Indication, 2018 to 2030
    • 5.4.1. Asthma
      • 5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.2. COPD
      • 5.4.2.1. COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.3. Others
      • 5.4.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Smart Inhalers Market: Distribution Channel Estimates& Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Distribution Channel Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Smart Inhalers Market: By Distribution Channel, 2018 to 2030
    • 6.4.1. Hospital Pharmacies
      • 6.4.1.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. Retail Pharmacies
      • 6.4.2.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Online Pharmacies
      • 6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Smart Inhalers Market: End Use Estimates& Trend Analysis

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2023 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Smart Inhalers Market: By End Use, 2018 to 2030
    • 7.4.1. Hospital
      • 7.4.1.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2. Homecare Settings
      • 7.4.2.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Others
      • 7.4.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Smart Inhalers Market: Regional Estimates & Trend Analysis by Country, Type, Indication, Distribution Channel, End Use

  • 8.1. Definition and Scope
  • 8.2. Regional Market Share Analysis, 2023 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. SWOT Analysis
    • 8.5.1. North America
    • 8.5.2. Europe
    • 8.5.3. Asia Pacific
    • 8.5.4. Latin America
    • 8.5.5. Middle East & Africa
  • 8.6. Smart Inhalers Market Share, By Region, 2023 & 2030, USD Billion
  • 8.7. North America
    • 8.7.1. North America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.7.2. U.S.
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. U.S. Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.7.3. Canada
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Canada Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.8. Europe
    • 8.8.1. Europe Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.2. UK
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. U.K. Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.3. Germany
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Germany Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.4. France
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. France Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.5. Italy
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Italy Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.6. Spain
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Spain Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.8.7. Russia
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Sweden Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.9. Asia Pacific
    • 8.9.1. Asia Pacific Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.2. China
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. China Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.3. Japan
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Japan Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.4. India
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.4.3. Competitive Insights
      • 8.9.4.4. India Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.5. South Korea
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.5.3. Competitive Insights
      • 8.9.5.4. South Korea Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.6. Australia
      • 8.9.6.1. Key Country Dynamics
      • 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.6.3. Competitive Insights
      • 8.9.6.4. Australia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.9.7. SIngapore
      • 8.9.7.1. Key Country Dynamics
      • 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.7.3. Competitive Insights
      • 8.9.7.4. Thailand Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.10. Latin America
    • 8.10.1. Latin America Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.10.2. Brazil
      • 8.10.2.1. Key Country Dynamics
      • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. Brazil Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.10.3. Mexico
      • 8.10.3.1. Key Country Dynamics
      • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. Mexico Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.10.4. Argentina
      • 8.10.4.1. Key Country Dynamics
      • 8.10.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.4.3. Competitive Insights
      • 8.10.4.4. Argentina Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.11. Middle East and Africa
    • 8.11.1. Middle East and Africa Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.2. South Africa
      • 8.11.2.1. Key Country Dynamics
      • 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.2.3. Competitive Insights
      • 8.11.2.4. South Africa Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.3. Saudi Arabia
      • 8.11.3.1. Key Country Dynamics
      • 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.3.3. Competitive Insights
      • 8.11.3.4. Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.11.4. UAE
      • 8.11.4.1. Key Country Dynamics
      • 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.4.3. Competitive Insights
      • 8.11.4.4. UAE Smart Inhalers Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
  • 9.6. Company Profiles
    • 9.6.1. Presspart Verwaltungs GmbH.
      • 9.6.1.1. Participant's Overview
      • 9.6.1.2. Financial Performance
      • 9.6.1.3. Product Benchmarking
      • 9.6.1.4. Recent Developments
    • 9.6.2. Personal Air Quality Systems Pvt Ltd
      • 9.6.2.1. Participant's Overview
      • 9.6.2.2. Financial Performance
      • 9.6.2.3. Product Benchmarking
      • 9.6.2.4. Recent Developments
    • 9.6.3. COHERO Health Inc. (AptarGroup, Inc.)
      • 9.6.3.1. Participant's Overview
      • 9.6.3.2. Financial Performance
      • 9.6.3.3. Product Benchmarking
      • 9.6.3.4. Recent Developments
    • 9.6.4. Cognita Labs
      • 9.6.4.1. Participant's Overview
      • 9.6.4.2. Financial Performance
      • 9.6.4.3. Product Benchmarking
      • 9.6.4.4. Recent Developments
    • 9.6.5. adherium
      • 9.6.5.1. Participant's Overview
      • 9.6.5.2. Financial Performance
      • 9.6.5.3. Product Benchmarking
      • 9.6.5.4. Recent Developments
    • 9.6.6. Amiko Digital Health Limited.
      • 9.6.6.1. Participant's Overview
      • 9.6.6.2. Financial Performance
      • 9.6.6.3. Product Benchmarking
      • 9.6.6.4. Recent Developments
    • 9.6.7. Teva Pharmaceuticals Industries Ltd.
      • 9.6.7.1. Participant's Overview
      • 9.6.7.2. Financial Performance
      • 9.6.7.3. Product Benchmarking
      • 9.6.7.4. Recent Developments
    • 9.6.8. Propeller Health (ResMed)
      • 9.6.8.1. Participant's Overview
      • 9.6.8.2. Financial Performance
      • 9.6.8.3. Product Benchmarking
      • 9.6.8.4. Recent Developments
    • 9.6.9. Novartis AG
      • 9.6.9.1. Participant's Overview
      • 9.6.9.2. Financial Performance
      • 9.6.9.3. Product Benchmarking
      • 9.6.9.4. Recent Developments
    • 9.6.10. Pneuma Respiratory Inc.
      • 9.6.10.1. Participant's Overview
      • 9.6.10.2. Financial Performance
      • 9.6.10.3. Product Benchmarking
      • 9.6.10.4. Recent Developments
    • 9.6.11. 3M
      • 9.6.11.1. Participant's Overview
      • 9.6.11.2. Financial Performance
      • 9.6.11.3. Product Benchmarking
      • 9.6.11.4. Recent Developments
    • 9.6.12. AireHealth, Inc.
      • 9.6.12.1. Participant's Overview
      • 9.6.12.2. Financial Performance
      • 9.6.12.3. Product Benchmarking
      • 9.6.12.4. Recent Developments
    • 9.6.13. FindAir Sp. z o.o
      • 9.6.13.1. Participant's Overview
      • 9.6.13.2. Financial Performance
      • 9.6.13.3. Product Benchmarking
      • 9.6.13.4. Recent Developments